Related references
Note: Only part of the references are listed.SIGLEC1 (CD169) as a potential diagnostical screening marker for monogenic interferonopathies
Banu Orak et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2021)
Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019
Anne-Sophie Bedin et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Virological assessment of hospitalized patients with COVID-2019
Roman Woelfel et al.
NATURE (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Qian Zhang et al.
SCIENCE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
Role of the interferons in CD64 and CD169 expressions in whole blood: Relevance in the balance between viral- or bacterial-oriented immune responses
Penelope Bourgoin et al.
IMMUNITY INFLAMMATION AND DISEASE (2020)
Anti-Siglec-1 antibodies block Ebola viral uptake and decrease cytoplasmic viral entry
Daniel Perez-Zsolt et al.
NATURE MICROBIOLOGY (2019)
HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells
Maria Pino et al.
RETROVIROLOGY (2015)
Share Paper
